Contact Veyvora | Product, COA, Shipping and Order Support

By the end of this page you will know which email address to use for your specific question, what information to include so your message is resolved in a single exchange, and how to obtain or verify a certificate of analysis (COA) for a specific batch. All materials and discussion here are for laboratory and in-vitro research use only. No human treatment, administration or dosing questions are in scope.

Three addresses handle everything: support@veyvora.com for existing orders, hello@veyvora.com for general product and pre-order enquiries, and compliance@veyvora.com for COAs and compliance questions. Veyvora states it usually replies within one business day (Veyvora, 2026).

---

Key Takeaways

• Three distinct email addresses handle orders, general enquiries, and COA/compliance questions respectively, routing to the wrong one adds at least one exchange before the right person sees it.
• A well-formed message (compound name, batch number, format, destination, question type) is what makes a one-business-day turnaround realistic.
• COAs are batch-specific; a document from a different lot does not authenticate the vial in hand.
• Whether a product is classified as a medicine is a determination made under the Human Medicines Regulations 2012 by the MHRA; our support team can help with documentation but cannot make that legal determination.

---

Choose the Right Contact Route

Routing your message correctly from the outset is the single most effective step you can take. A misdirected message adds at least one exchange before the right person sees it.

Enquiry type	Address	Notes
Existing orders & dispatch	support@veyvora.com	Include order reference and destination
General product & pre-order	hello@veyvora.com	Catalogue, SKU, shipping-to-country questions
COA, compliance & batch	compliance@veyvora.com	Quote batch/lot number and compound name

These three addresses are the only contact routes Veyvora uses; secondary listings or forum posts do not reflect how the company wishes to be contacted (Veyvora, 2026).

Browse Veyvora’s research-peptide catalogue first to confirm the product name before writing, particularly where the correct compound or SKU is uncertain.

---

Information to Include

A well-formed message lets the support team act without a clarifying round-trip. Veyvora states that researchers should include the compound name, batch number, format, destination and question type so the team can route the request efficiently (Veyvora, 2026). Specifically, include:

• Compound name or SKU as it appears in the catalogue
• Order or reference number, if one has been issued
• Batch or lot identifier, if known
• Format and quantity (for example, lyophilised powder, 5 mg vial)
• Destination country, relevant for shipping and documentation queries
• Nature of the question: documentation, dispatch status, or batch verification

Titration, administration and human-use questions fall outside the scope of Veyvora’s research-supply support and will not be answered. Medical information about end-users is neither required nor appropriate.

---

Certificates and Batch Questions

A COA is batch-specific. A generic product page, a published paper on the peptide’s chemistry, or a COA from a different lot does not authenticate the vial in hand. Contact compliance@veyvora.com and quote the exact batch or lot number printed on the packaging.

Veyvora states that each batch is independently assayed by Asterion and re-checked in-house using high-performance liquid chromatography (HPLC), mass spectrometry and endotoxin assay, against an HPLC purity specification of ≥ 98.0% (Veyvora, 2026). Treat that as independently certified only where the COA you hold names the external laboratory and the test date. To understand what the assay language on a COA does and does not establish, see what HPLC purity does and does not prove.

Any figure, whether a purity percentage, an endotoxin level or a mass-spec result, that does not appear on the document you hold is unverified. Do not infer figures from another batch or from a product description; batch-to-batch variation makes such inferences unreliable. The compliance team can confirm whether a document is available, but they cannot create one retrospectively.

Cross-reference a received document against Veyvora’s records using the verify your batch against its COA tool before raising a support ticket.

---

Shipping and Order Support

For dispatch, transit and receipt questions, contact support@veyvora.com and quote your order reference in the subject line. Veyvora states that orders are dispatched within 24 hours under documented cold-chain conditions in an insulated bag with a gel ice pack (Veyvora, 2026).

A parcel that arrives warm, or with compromised insulation or a thawed gel pack, warrants a check of storage and stability guidance before you decide whether the material remains fit for the intended assay. That page covers the conditions under which short excursions are or are not expected to affect stability, which is the first question the support team will raise in any case.

Delivery times, carrier names, import duties and country-specific restrictions vary by destination. None of those figures appear here because no verified 2025–2026 Veyvora shipping terms are available in this source set; the support team is the correct place to confirm them for your specific destination.

Regulatory classification of research peptides, including whether a consignment constitutes a medicinal product under UK law, is determined by the Human Medicines Regulations 2012 [1] and assessed by the MHRA [2], not resolved by a courier update or a support ticket. A research-only supply framing does not by itself settle that question; consult the MHRA’s borderline guidance on the date of your enquiry, as that guidance is updated independently of the 2012 instrument.

---

Have your lot number and compound name ready, then send your question to compliance@veyvora.com for batch and COA matters, or your order reference to support@veyvora.com for shipping queries.

Sources

[1] legislation.gov.uk, https://www.legislation.gov.uk/uksi/2012/1916/contents [2] [Withdrawn] Decide if your product is a medicine or a medical device - GOV.UK, gov.uk, 2020, https://www.gov.uk/guidance/decide-if-your-product-is-a-medicine-or-a-medical-device